Saccharomyces cerevisiae var. boulardii as a eukaryotic probiotic and its therapeutic functions

Fuller, in 1989, described probiotic microorganisms as “a live microbial feed supplement,which beneficially affects the host animal, by improving its intestinal microbial balance”.Saccharomyces cerevisiae var. boulardii (S.boulardii) is an accurate probiotic yeast idol.The detection and budding of S.boulardiiis firmly related to the impression of healthinessto promote microorganisms from foodstuff. S.boulardiiis similar to S.cerevisiae in that itequally does not have the capability to penetrate into tissues like the Candida species isable to, hence they are not invasive. Some printed medicinal researches have shown theeffectiveness and safety of S.boulardii for different illness indications in both adults andchildren. On the subject of the therapy employed, diverse indications of S.boulardii are asfollows: Anticipation of antibiotic related diarrhea, recurring Clostridium difficile relateddiarrhea and colitis, severe viral and bacterial diarrhea, travelers’ diarrhea, antiinflammatorybowel syndromes as well as Crohn's disease and so on. These days,S.boulardii is regularly marketed as a probiotic in a lyophilized shape and is oftenreferred to as S.boulardii lyo.